These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 350021)

  • 21. The treatment of psoriasis with 0.1% domoprednate (a D-homocorticosteroid) and 0.1% betamethasone valerate ointment. A double-blind, randomized trial.
    Christiansen JV; Foged E; Holm P; Jørgensen AS; Reymann F
    Dermatologica; 1985; 170(4):195-8. PubMed ID: 3888709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of short-course class 1 topical glucocorticoid under occlusion for the rapid control of erythrodermic psoriasis.
    Arbiser JL; Grossman K; Kaye E; Arndt KA
    Arch Dermatol; 1994 Jun; 130(6):704-6. PubMed ID: 8002640
    [No Abstract]   [Full Text] [Related]  

  • 23. A double-blind comparison of quarter strength clobetasol propionate in Unguentum Merck with betamethasone valerate in psoriasis.
    Stankler L
    Br J Clin Pract; 1983; 37(11-12):389-91. PubMed ID: 6367795
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of dietary supplementation of fish oil on neutrophil and epidermal fatty acids. Modulation of clinical course of psoriatic subjects.
    Ziboh VA; Cohen KA; Ellis CN; Miller C; Hamilton TA; Kragballe K; Hydrick CR; Voorhees JJ
    Arch Dermatol; 1986 Nov; 122(11):1277-82. PubMed ID: 3022655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Metabolism of arachidonic acid of the skin and its significance in the pathophysiology of inflammatory dermatosis].
    Ruzicka T
    Hautarzt; 1984 Jul; 35(7):337-43. PubMed ID: 6432739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Etretinate (Tigason) and betamethasone valerate (Celeston valerate) in the treatment of psoriasis. A double-blind, randomized, multicenter trial.
    Christiansen JV; Holm P; Møller R; Reymann F; Schmidt H
    Dermatologica; 1982 Sep; 165(3):204-7. PubMed ID: 6751889
    [No Abstract]   [Full Text] [Related]  

  • 27. Betamethasone dipropionate: a new topical agent for the treatment of psoriasis.
    Superfon N; Charney P
    J Am Osteopath Assoc; 1975 Nov; 75(3):340-3. PubMed ID: 1041744
    [No Abstract]   [Full Text] [Related]  

  • 28. Transepidermal elimination following the use of a topical adrenal steroid.
    Katz R; Hood AF
    Arch Dermatol; 1985 Mar; 121(3):412-3. PubMed ID: 3977366
    [No Abstract]   [Full Text] [Related]  

  • 29. A controlled clinical trial of a new formulation of betamethasone dipropionate cream in once-daily treatment of psoriasis.
    Ellis CN; Katz HI; Rex IH; Shavin JS; Van Scott EJ; VanderPloeg D
    Clin Ther; 1989; 11(6):768-74. PubMed ID: 2692821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A separation of clinical from epidermal thinning effect in the topical glucocorticoid clobetasone butyrate.
    Stevanovic DV; Wilson L; Sparkes CG
    Br J Dermatol; 1977 Jan; 96(1):67-70. PubMed ID: 320995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Betamethasone dipropionate cream for the treatment of psoriasis. A collaborative evaluation.
    Charney P
    Arch Dermatol; 1976 May; 112(5):681-3. PubMed ID: 776090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcipotriol and betamethasone dipropionate for the treatment of psoriasis: a 52-week study.
    Toole JW
    Skin Therapy Lett; 2007 May; 12(4):1-3. PubMed ID: 17551662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The treatment of psoriasis with fluocinonide. A comparative double-blind clinical trial with betamethasone valerate.
    Feuerman E
    Z Hautkr; 1974 Jan; 49(2):75-8. PubMed ID: 4591248
    [No Abstract]   [Full Text] [Related]  

  • 34. [Biochemical disorders in psoriasis].
    Toruń B
    Wiad Lek; 1986 Feb; 39(3):198-202. PubMed ID: 3012888
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of guttate psoriasis with a new two-compound product containing calcipotriol and betamethasone dipropionate.
    Vakirlis E; Kastanis A; Lazaridou E; Loannides D; Chrysomallis F
    Int J Clin Pharmacol Res; 2005; 25(4):165-8. PubMed ID: 16402632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison between 2 steroid dosage forms in psoriasis and eczema].
    Björnberg A; Hellgren L
    Z Hautkr; 1975; Suppl 2():13-5. PubMed ID: 779298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Skin colour changes in psoriasis responding to treatment with betamethasone-17-valerate under occlusion.
    Tring FC
    Acta Derm Venereol; 1973; 53(3):199-202. PubMed ID: 4124011
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapy of erythrosquamous dermatoses. Betamethasone dipropionate plus salicylic acid in comparison with betamethasone dipropionate solution].
    Nolting S; Hagemeier HH
    Fortschr Med; 1983 Oct; 101(37):1679-83. PubMed ID: 6227542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of scalp psoriasis with betamethasone dipropionate and calcipotriol two-compound product.
    Cassano N; Vena GA
    Acta Derm Venereol; 2007; 87(1):85-6. PubMed ID: 17225026
    [No Abstract]   [Full Text] [Related]  

  • 40. [Double-blind-study on treatment with clobetasol-17-propionate and other topical corticoids (author's transl)].
    Beck M; Berger C; Filipp N; Hundertmark U; Loewel R
    Z Hautkr; 1981 Aug; 56(16):1066-70. PubMed ID: 7027655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.